SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010492
Filing Date
2017-05-11
Accepted
2017-05-11 15:05:56
Documents
75
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20170331.htm 10-Q 1386503
2 EX-31.1 reph-ex311_11.htm EX-31.1 17433
3 EX-31.2 reph-ex312_10.htm EX-31.2 16475
4 EX-32.1 reph-ex321_16.htm EX-32.1 8048
  Complete submission text file 0001564590-17-010492.txt   6443526

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20170331.xml EX-101.INS 1423728
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20170331.xsd EX-101.SCH 52116
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20170331_cal.xml EX-101.CAL 52254
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20170331_def.xml EX-101.DEF 187868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20170331_lab.xml EX-101.LAB 415344
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20170331_pre.xml EX-101.PRE 338668
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 17833891
SIC: 2834 Pharmaceutical Preparations